Growth Metrics

Sanara MedTech (SMTI) FCF Margin (2016 - 2025)

Sanara MedTech (SMTI) has disclosed FCF Margin for 15 consecutive years, with 4.25% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin fell 517.0% year-over-year to 4.25%, compared with a TTM value of 0.83% through Sep 2025, up 173.0%, and an annual FY2024 reading of 0.26%, up 514.0% over the prior year.
  • FCF Margin was 4.25% for Q3 2025 at Sanara MedTech, up from 3.49% in the prior quarter.
  • Across five years, FCF Margin topped out at 9.42% in Q3 2024 and bottomed at 27.62% in Q1 2022.
  • Average FCF Margin over 5 years is 9.15%, with a median of 8.96% recorded in 2024.
  • The sharpest move saw FCF Margin tumbled -819bps in 2021, then skyrocketed 2282bps in 2022.
  • Year by year, FCF Margin stood at 27.38% in 2021, then skyrocketed by 83bps to 4.56% in 2022, then decreased by -12bps to 5.1% in 2023, then soared by 164bps to 3.27% in 2024, then grew by 30bps to 4.25% in 2025.
  • Business Quant data shows FCF Margin for SMTI at 4.25% in Q3 2025, 3.49% in Q2 2025, and 15.88% in Q1 2025.